Opportunity Information: Apply for CDC RFA IP13 130101PPHF13
Apply for CDC RFA IP13 130101PPHF13
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "PPHF 2013 Immunization Increasing Human Papillomavirus (HPV) Vaccination Coverage Rates among Adolescents financed solely by 2013 Prevention and Public Health Funds" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.539 PPHF Capacity Building Assistance to Strengthen Public Health Immunization Infrastructure and Performance financed in pa.
- This funding opportunity was created on Aug 12, 2013 and posted on Aug 8, 2013.
- Applicants must submit their applications by Sep 9, 2013 Key Dates Letter of Intent Deadline August 16, 2013, 500 p.m. Eastern Time Application Deadline Date September 9, 2013, 500 p.m. Eastern Time. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $7,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
- The number of recipients for this funding is limited to 11 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- III. ELIGIBILITY INFORMATION Eligible Applicants The following recipients may submit an application Applicants must be one of the 64 Immunization Program awardees currently funded under CDC RFA IP13 1301 Immunization and Vaccines for Children Program to ensure availability of the necessary infrastructure to perform the activities required and the experience needed to complete the required functions successfully.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "PPHF 2013 Immunization Increasing Human Papillomavirus (HPV) Vaccination Coverage Rates among Adolescents" (Funding Opportunity Number CDC-RFA-IP13-130101PPHF13) was a discretionary CDC grant funded entirely through the 2013 Prevention and Public Health Fund (PPHF). Its overall goal was to raise HPV vaccination coverage among adolescents by strengthening how jurisdictions coordinate, communicate, and deliver HPV vaccination services, with an emphasis on improving completion of the then-recommended 3-dose HPV vaccine series in line with ACIP recommendations at the time.
At the core of the program was a multi-part strategy aimed at improving both demand for HPV vaccination and the health system processes that help adolescents start and finish the series. Applicants were expected to build a jurisdiction-wide, joint initiative that formally engaged immunization stakeholders, meaning the effort was not meant to be isolated within a single health department unit but instead organized across partners who influence adolescent vaccination. In parallel, grantees were expected to run a comprehensive public-facing communication campaign designed to reach parents, adolescents, and communities with clear messages about HPV vaccination, including its role in preventing HPV-related diseases and cancers.
A major operational requirement involved using Immunization Information Systems (IIS) to drive reminder and recall activities for adolescents ages 11 through 18. The preferred model was a centralized reminder/recall approach run through the jurisdiction, rather than leaving reminder systems entirely up to individual clinics, although the announcement allowed for provider-supported approaches when needed. This element reflected the program focus on building reliable infrastructure that could systematically identify adolescents who were due or overdue and prompt them to receive the next dose, improving series completion and reducing missed opportunities.
The opportunity also emphasized performance improvement at the provider level through assessment and feedback. Grantees were expected to evaluate how immunization providers were performing in administering HPV vaccine doses and completing the 3-dose series, then use feedback loops to help providers improve. This meant using data to identify gaps (for example, low initiation rates or poor follow-through on second and third doses) and implementing targeted quality improvement actions to address them.
Another central pillar was direct support and intervention aimed at immunization providers. The grant spelled out several provider-focused objectives: increasing provider knowledge about HPV-related diseases (including cancers), strengthening knowledge about HPV vaccine safety and effectiveness, improving the practical skills needed to deliver strong and effective vaccination recommendations, reducing missed clinical opportunities for on-time vaccination and series completion, and ultimately increasing HPV vaccine administration consistent with ACIP guidance. In practice, this implied training, toolkits, clinical workflow improvements, and reinforcing the importance of a clear provider recommendation, since provider recommendation is often a key driver of vaccine acceptance.
From an administrative and funding standpoint, the CDC anticipated making 11 awards with an estimated total program funding amount of $7,000,000. Individual awards were expected to range from $400,000 (floor) to $1,000,000 (ceiling). There was no cost-sharing or matching requirement. The funding instrument type was a grant, and the activity category was health. The CFDA number associated with the program was 93.539, described as PPHF capacity-building assistance to strengthen public health immunization infrastructure and performance.
Eligibility was limited and highly specific: only the 64 Immunization Program awardees already funded under CDC RFA IP13-1301 (Immunization and Vaccines for Children Program) could apply. This restriction was designed to ensure applicants already had the baseline immunization infrastructure, data systems, and program experience needed to quickly implement IIS-based interventions, provider assessment and feedback, and broad stakeholder initiatives without building a program from scratch.
Key dates reflected a short application window typical of targeted capacity-building funds. The posting date was August 8, 2013 (with creation dated August 12, 2013). A letter of intent was due August 16, 2013, by 5:00 p.m. Eastern Time. The application deadline was listed in the opportunity as September 9, 2013, by 5:00 p.m. Eastern Time (with an earlier reference to September 7 that was superseded by the September 9 closing date). The opportunity was archived on October 9, 2013. For applicants needing help accessing the full announcement, the CDC Procurement and Grants Office Technical Information Management Section (TIMS) was listed as the point of contact (phone 770-488-2700; email pgotim@cdc.gov).
Taken together, the grant was designed to move HPV vaccination rates by combining public communications, IIS-powered reminder/recall, data-driven provider performance feedback, and provider training focused on stronger recommendations and fewer missed opportunities, all implemented through existing jurisdictional immunization programs with established infrastructure.
Frequently Asked Questions (FAQs)
1) What is the full title of this grant opportunity?
The opportunity is titled "PPHF 2013 Immunization Increasing Human Papillomavirus (HPV) Vaccination Coverage Rates among Adolescents."
2) What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC-RFA-IP13-130101PPHF13.
3) Which agency offered this grant?
This was a discretionary grant offered by the Centers for Disease Control and Prevention (CDC).
4) What was the source of funding for this program?
The program was funded entirely through the 2013 Prevention and Public Health Fund (PPHF).
5) What was the overall goal of the grant?
The overall goal was to raise HPV vaccination coverage among adolescents by strengthening how jurisdictions coordinate, communicate, and deliver HPV vaccination services.
6) What specific vaccination outcome was emphasized?
The program emphasized improving completion of the then-recommended 3-dose HPV vaccine series, consistent with ACIP recommendations at the time.
7) Who was the target population for vaccination-related interventions?
The grant focused on adolescents, specifically ages 11 through 18 for IIS-based reminder/recall activities.
8) What types of strategies were expected from applicants?
Applicants were expected to use a multi-part strategy that addressed both demand for HPV vaccination (through communications) and health system processes that help adolescents start and finish the vaccine series (through IIS reminder/recall, provider assessment and feedback, and provider-focused support).
9) What does it mean that applicants needed a jurisdiction-wide, joint initiative?
Applicants were expected to build a jurisdiction-wide effort that formally engaged immunization stakeholders. The initiative was not meant to be isolated within a single health department unit, but organized across partners who influence adolescent vaccination.
10) Was a public communication campaign required?
Yes. Grantees were expected to run a comprehensive public-facing communication campaign designed to reach parents, adolescents, and communities with clear messages about HPV vaccination, including its role in preventing HPV-related diseases and cancers.
11) What role did Immunization Information Systems (IIS) play in the program?
IIS was a major operational requirement. Grantees were expected to use IIS to drive reminder and recall activities for adolescents ages 11 through 18 to help identify those due or overdue for doses and prompt vaccination to improve series completion.
12) Was there a preferred model for reminder/recall?
Yes. The preferred model was a centralized reminder/recall approach run through the jurisdiction, rather than leaving reminder systems entirely to individual clinics.
13) Were provider-supported reminder/recall approaches allowed?
Yes. While centralized reminder/recall was preferred, the announcement allowed for provider-supported approaches when needed.
14) What is meant by "assessment and feedback" at the provider level?
Grantees were expected to evaluate provider performance in administering HPV vaccine doses and completing the 3-dose series, then provide feedback to help providers improve. This included using data to identify gaps such as low initiation rates or poor follow-through on later doses and implementing targeted quality improvement actions.
15) What kinds of provider-focused improvements did the grant emphasize?
The grant emphasized direct support and intervention aimed at immunization providers, including improving provider knowledge about HPV-related diseases (including cancers), strengthening knowledge about HPV vaccine safety and effectiveness, improving skills for delivering strong and effective vaccination recommendations, reducing missed clinical opportunities for on-time vaccination and series completion, and increasing HPV vaccine administration consistent with ACIP guidance.
16) What kinds of activities were implied to support providers?
The description implies activities such as training, toolkits, clinical workflow improvements, and reinforcing the importance of a clear provider recommendation to increase vaccine acceptance and reduce missed opportunities.
17) How many awards did CDC anticipate making?
CDC anticipated making 11 awards.
18) What was the estimated total funding amount for the program?
The estimated total program funding amount was $7,000,000.
19) What was the expected funding range for individual awards?
Individual awards were expected to range from $400,000 (floor) to $1,000,000 (ceiling).
20) Was cost-sharing or matching required?
No. There was no cost-sharing or matching requirement.
21) What was the funding instrument type?
The funding instrument type was a grant.
22) What was the activity category?
The activity category was health.
23) What CFDA number was associated with this program?
The CFDA number was 93.539, described as PPHF capacity-building assistance to strengthen public health immunization infrastructure and performance.
24) Who was eligible to apply?
Eligibility was limited to only the 64 Immunization Program awardees already funded under CDC RFA IP13-1301 (Immunization and Vaccines for Children Program).
25) Why was eligibility restricted to those specific awardees?
The restriction was designed to ensure applicants already had baseline immunization infrastructure, data systems, and program experience needed to quickly implement IIS-based interventions, provider assessment and feedback, and broad stakeholder initiatives without building a program from scratch.
26) When was the opportunity posted?
The posting date was August 8, 2013 (with creation dated August 12, 2013).
27) Was a letter of intent required, and when was it due?
A letter of intent was due August 16, 2013, by 5:00 p.m. Eastern Time.
28) What was the application deadline?
The application deadline was September 9, 2013, by 5:00 p.m. Eastern Time.
29) Why are there two different application deadline dates referenced (September 7 and September 9)?
The opportunity materials included an earlier reference to September 7, but that was superseded by the September 9 closing date listed in the opportunity.
30) When was the opportunity archived?
The opportunity was archived on October 9, 2013.
31) What was the listed point of contact for help accessing the full announcement?
The CDC Procurement and Grants Office Technical Information Management Section (TIMS) was listed as the point of contact. Phone: 770-488-2700. Email: pgotim@cdc.gov.
32) What were the core program pillars described in the opportunity summary?
The grant was designed to improve HPV vaccination rates by combining: a public communication campaign, IIS-powered reminder/recall, data-driven provider performance assessment and feedback, and provider training/support focused on stronger recommendations and fewer missed opportunities, all implemented through existing jurisdictional immunization programs with established infrastructure.
Browse more opportunities from the same category: Health
Next opportunity: Increased Knowledge and Innovative Strategies to Reduce HIV IncidenceiKnow Projects (R01)
Previous opportunity: BLM WY Wildlife Aerial Survey
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA IP13 130101PPHF13
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA IP13 130101PPHF13) also looked into and applied for these:
| Funding Opportunity |
|---|
| Methods for Prevention Packages Program III (MP3 III) (R01) Apply for PAR 13 322 Funding Number: PAR 13 322 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| IIS Sentinel Site Pandemic Preparedness and Response Planning Apply for CDC RFA IP13 130201SUPP13 Funding Number: CDC RFA IP13 130201SUPP13 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| 2014 NIH Pioneer Award Program (DP1) Apply for RFA RM 13 006 Funding Number: RFA RM 13 006 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| 2014 NIH Directors New Innovator Award Program (DP2) Apply for RFA RM 13 007 Funding Number: RFA RM 13 007 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Limited Pilot for NIGMS Legacy Community Wide Scientific Resources (R24) Apply for PAR 13 324 Funding Number: PAR 13 324 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Grants for Early Medical/Surgical Specialists Transition to Aging Research (GEMSSTAR) (R03) Apply for RFA AG 14 010 Funding Number: RFA AG 14 010 Agency: National Institutes of Health Category: Health Funding Amount: $75,000 |
| NIA Revision and Resubmission Program Project Applications (P01) Apply for PAR 13 329 Funding Number: PAR 13 329 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Audacious Goals Initiative High Priority Research Area Intersection of Aging and Biological Mechanisms of Eye Disease (R01) Apply for PA 13 332 Funding Number: PA 13 332 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Bridges to Baccalaureate Program (R25) Apply for PAR 13 333 Funding Number: PAR 13 333 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| State and Regional Primary Care Association (PCA) Cooperative Agreements for Alaska, Georgia, and Wyoming Apply for HRSA 14 032 Funding Number: HRSA 14 032 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| National Indian Health Outreach and Education II Apply for HHS 2013 IHS NIHOE 0002 Funding Number: HHS 2013 IHS NIHOE 0002 Agency: Indian Health Service Category: Health Funding Amount: $150,000 |
| NIH Directors Early Independence Awards (DP5) Apply for RFA RM 13 009 Funding Number: RFA RM 13 009 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Onsite Tools and Technologies for Heart, Lung, and Blood Clinical Research Point of Care SBIR (R43/R44) Apply for RFA HL 14 011 Funding Number: RFA HL 14 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Onsite Tools and Technologies for Heart, Lung, and Blood Clinical Research Point of Care STTR (R41/R42) Apply for RFA HL 14 017 Funding Number: RFA HL 14 017 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Service Area Competition Additional Area (Round Mountain, CA and Cheyenne, WY) Apply for HRSA 14 100 Funding Number: HRSA 14 100 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Smallpox Research Oversight Activities Apply for EP IDS 13 003 Funding Number: EP IDS 13 003 Agency: Assistant Secretary for Preparedness and Response Category: Health Funding Amount: $290,000 |
| Library of Integrated Network Based Cellular Signatures (LINCS) Perturbation Induced Data and Signature Generation Centers (U54) Apply for RFA RM 13 013 Funding Number: RFA RM 13 013 Agency: National Institutes of Health Category: Health Funding Amount: $1,700,000 |
| State Vital Statistics Improvement Program Apply for CDC RFA SH12 12010203SUPP13 Funding Number: CDC RFA SH12 12010203SUPP13 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $110,000 |
| Cooperative Agreement on Occupational Health with the World Health Organization (WHO) Implementing World Health Assembly Resolution 60.26 Global Plan of Action for Workers Health 2008 2017 Apply for RFA OH 14 002 Funding Number: RFA OH 14 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| NHLBI Investigator Initiated Resource Related Research Projects (R24) Apply for PAR 13 335 Funding Number: PAR 13 335 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA IP13 130101PPHF13", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.